Skip to main content
Log in

No increased cancer risk with ARBs, says FDA

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. FDA.FDA Drug Safety Communication: No increase in risk of cancer with certain blood pressure drugs--Angiotensin Receptor Blockers (ARBs). Internet Document: [1 page], 3 Jun 2011. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

No increased cancer risk with ARBs, says FDA. React. Wkly. 1355, 3 (2011). https://doi.org/10.2165/00128415-201113550-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113550-00008

Keywords

Navigation